Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

TSX/GILD stock hub

TSX/GILD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/GILDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

223.2B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/GILD

In the news

Latest news · TSX/GILD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E17.4

P25 7.4P50 15.6P75 34.3

ROE43.4

P25 -121.5P50 -40.9P75 0.5

ROIC27.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/GILD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	17,000
Employees Change	-600%
Employees Change Percent	-3.41
Enterprise value	CAD 238.7B
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CAD 223.2B
Price	CAD 26.72
Price currency	CAD
Rev Per Employee	2,441,605.47x
Sector	Healthcare
Sic	2836
Symbol	tsx/GILD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.76%
EV Earnings	18.55x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	16.71x
EV/Sales	5.86x
FCF yield	6.4%
P/B ratio	6.82x
P/E ratio	17.35x
P/S ratio	5.38x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	CAD 32.9B
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	CAD 12.9B
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	CAD 756,720
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	32.53%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.53
Assets	CAD 78.6B
Cash	CAD 13.7B
Current Assets	CAD 25.5B
Current Liabilities	CAD 13B
Debt	CAD 31B
Debt EBITDA	CAD 1.49
Debt Equity	CAD 0.95
Debt FCF	CAD 2.17
Equity	CAD 32.7B
Interest Coverage	11.94
Liabilities	CAD 45.8B
Long Term Assets	CAD 53.1B
Long Term Liabilities	CAD 32.9B
Net Cash	CAD -15.9B
Net Cash By Market Cap	CAD -7.11
Net Debt EBITDA	CAD 0.77
Net Debt Equity	CAD 0.49
Net Debt FCF	CAD 1.11
Tangible Book Value	CAD -1.6B
Tangible Book Value Per Share	CAD -1.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	CAD 922.7M
Quick ratio	1.54
Working Capital	CAD 12.8B
Working Capital Turnover	CAD 6.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CAD 0.66
Dividend Years	2
Dividend Yield	2.46%
Ex Div Date	2026-03-13
Last Dividend	CAD 0.17
Payout Frequency	Quarterly
Payout Ratio	6.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	32.51%
200-day SMA	25.83
50-day SMA	28.53
50-day SMA vs 200-day SMA	50over200
All Time High	31.8
All Time High Change	-15.97%
All Time High Date	2026-02-13
All Time Low	20.08
All Time Low Change	33.07%
All Time Low Date	2025-05-12
ATR	0.44
Ch YTD	5.65
High	26.91
High52	31.8
High52 Date	2026-02-13
High52ch	-15.97%
Low	26.62
Low52	20.08
Low52 Date	2025-05-12
Low52ch	33.07%
Ma50ch	-6.35%
Price vs 200-day SMA	3.45%
RSI	42.08
RSI Monthly	0
RSI Weekly	48.9
Sharpe ratio	0.79x
Sortino ratio	1.47
Total Return	2.8%
Tr YTD	6.25
Tr1m	-5.45%
Tr1w	-0.67%
Tr3m	-14.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 16.7B
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-3,816,803,600
Shares Insiders	0.1%
Shares Institutions	88.48%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 13B
Average Volume	9,895.7x
Bv Per Share	26.43
CAPEX	CAD -804M
Ch1m	-5.45
Ch1w	-0.67
Ch1y	29.08
Ch3m	-14.55
Ch6m	10
Change	-1.98%
Change From Open	-0.26
Close	27.26
Days Gap	-1.72
Depreciation Amortization	3,763,488,650
Dollar Volume	489,296.6
Earnings Date	2026-05-07
EBIT	CAD 16.7B
EBITDA	CAD 20.6B
EPS	CAD 10.26
F Score	8
FCF	CAD 14.3B
FCF EV Yield	5.98x
Financing CF	-11,945,769,880
Fiscal Year End	December
Founded	1,987
Goodwill	11,365,653,700
Graham Number	11.64724
Graham Upside	-56.41
Income Tax	CAD 2.1B
Investing CF	-3,640,402,880
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	CAD 38.5
Lynch Upside	44.08
Ma150	26.61
Ma150ch	0.42%
Ma20	27.31
Ma20ch	-2.15%
Net CF	-414,570,420
Next Earnings Date	2026-08-06
Open	26.79
P FCF Ratio	15.63
P OCF Ratio	14.8
Payment Date	2026-04-07
Position In Range	34.48
Ppne	7,707,427,900
Price Date	2026-05-08
Price EBITDA	CAD 10.85
Relative Volume	1.85x
Revenue	41,507,292,960x
SBC By Revenue	3.04x
Share Based Comp	1,260,461,580
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	11.35%
Volume	18,312
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSX/GILD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$0.66 annual per share

Payout ratio

+6.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-03-13

Performance

TSX/GILD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/GILD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TSX/GILD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

+3.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/GILD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/GILD stock rating?

tsx/GILD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/GILD analysis?

The full report lives at /stocks/tsx/GILD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/GILD?

The latest report frames tsx/GILD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/GILD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.